Research ExplorerJournalsFUTURE ONCOL

FUTURE ONCOL - Future Oncology

Bibliographical data

ISSNs1479-6694
Electronic ISSN 1744-8301

Publications

Plain language summary of the MAIA study of daratumumab plus lenalidomide and dexamethasone for the treatment of people with newly diagnosed multiple myeloma
Facon, T., Kumar, S. K., Plesner, T., Orlowski, R. Z., Moreau, P., Bahlis, N., Basu, S., Nahi, H., Hulin, C., Quach, H., Goldschmidt, H., Perrot, A., Weisel, K., Raje, N., Macro, M., Frenzel, L., Leleu, X., Wang, J., Rampelbergh, R. V., Uhlar, C. M., Vermeulen, J., Duran, J., Borgsten, F. & Usmani, S. Z., 04.2023, In: FUTURE ONCOL. 19, 13, p. 887-895 9 p.

Research output: SCORING: Contribution to journal › SCORING: Review article › Research

Atezolizumab and bevacizumab with transarterial chemoembolization in hepatocellular carcinoma: the DEMAND trial protocol
Khaled, N. B., Seidensticker, M., Ricke, J., Mayerle, J., Oehrle, B., Rössler, D., Teupser, D., Ehmer, U., Bitzer, M., Waldschmidt, D., Fuchs, M., Reuken, P. A., Lange, C. M., Wege, H., Kandulski, A., Dechêne, A., Venerito, M., Berres, M-L., Luedde, T., Kubisch, I., Reiter, F. P. & De Toni, E. N., 04.2022, In: FUTURE ONCOL. 18, 12, p. 1423-1435 13 p.

Research output: SCORING: Contribution to journal › SCORING: Review article › Research

A Phase I dose-escalation study of third-line regorafenib with trifluridine/tipiracil in metastatic colorectal cancer
Moehler, M., Michel, M., Stein, A., Trojan, J., Marquardt, J., Tintelnot, J., Waidmann, O., Weinmann, A., Woerns, M-A., Schroeder, H., Maenz, M. & Foerster, F., 09.2021, In: FUTURE ONCOL. 17, 25, p. 3309-3319 11 p.

Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

Ixazomib-lenalidomide-dexamethasone in routine clinical practice:effectiveness in relapsed/refractory multiple myeloma
Hájek, R., Minařík, J., Straub, J., Pour, L., Jungova, A., Berdeja, J. G., Boccadoro, M., Brozova, L., Spencer, A., Rhee, F. V., Vela-Ojeda, J., Thompson, M. A., Abonour, R., Chari, A., Cook, G., Costello, C. L., Davies, F. E., Hungria, V. T., Lee, H. C., Leleu, X., Puig, N., Rifkin, R. M., Terpos, E., Usmani, S. Z., Weisel, K. C., Zonder, J. A., Bařinová, M., Kuhn, M., Šilar, J., Čápková, L., Galvez, K., Lu, J., Elliott, J., Stull, D. M., Ren, K. & Maisnar, V., 07.2021, In: FUTURE ONCOL. 17, 19, p. 2499-2512 14 p.

Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

Belantamab mafodotin in combination with novel agents in relapsed/refractory multiple myeloma: DREAMM-5 study design
Nooka, A. K., Weisel, K., van de Donk, N. W., Routledge, D., Otero, P. R., Song, K., Quach, H., Callander, N., Minnema, M. C., Trudel, S., Jackson, N. A., Ahlers, C. M., Im, E., Cheng, S., Smith, L., Hareth, N., Ferron-Brady, G., Brouch, M., de Oca, R. M., Paul, S., Holkova, B., Gupta, I., Kremer, B. E. & Richardson, P., 06.2021, In: FUTURE ONCOL. 17, 16, p. 1987-2003 17 p.

Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

Real-world outcomes in patients with metastatic renal cell carcinoma according to risk factors: the STAR-TOR registry
Strauss, A., Schmid, M., Rink, M., Moran, M., Bernhardt, S., Hubbe, M., Bergmann, L., Schlack, K. & Boegemann, M., 06.2021, In: FUTURE ONCOL. 17, 18, p. 2325-2338 14 p.

Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

Effect of comorbidities/comedications on sunitinib outcomes for metastatic renal cell carcinoma: the STAR-TOR registry
Boegemann, M., Schlack, K., Rink, M., Bernhardt, S., Moran, M., Hubbe, M., Bergmann, L., Schmid, M. & Strauss, A., 12.2020, In: FUTURE ONCOL. 16, 35, p. 2939-2948 10 p.

Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

Phase III study of nivolumab alone or combined with ipilimumab as immunotherapy versus standard of care in resectable head and neck squamous cell carcinoma
Zech, H. B., Moeckelmann, N., Boettcher, A., Muenscher, A., Binder, M., Vettorazzi, E., Bokemeyer, C., Schafhausen, P., Betz, C. S. & Busch, C-J., 12.2020, In: FUTURE ONCOL. 16, 36, p. 3035-3043 9 p.

Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

INSIGHT MM: a large, global, prospective, non-interventional, real-world study of patients with multiple myeloma
Costello, C., Davies, F. E., Cook, G., Vela-Ojeda, J., Omel, J., Rifkin, R. M., Berdeja, J., Puig, N., Usmani, S. Z., Weisel, K., Zonder, J. A., Terpos, E., Spencer, A., Leleu, X., Boccadoro, M., Thompson, M. A., Romanus, D., Stull, D. M. & Hungria, V., 05.2019, In: FUTURE ONCOL. 15, 13, p. 1411-1428 18 p.

Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

Chemotherapy-induced neutropenia/febrile neutropenia prophylaxis with biosimilar filgrastim in solid tumors versus hematological malignancies: MONITOR-GCSF study
Ludwig, H., Bokemeyer, C., Aapro, M., Boccadoro, M., Gascón, P., Denhaerynck, K., Krendyukov, A., Abraham, I. & MacDonald, K., 03.2019, In: FUTURE ONCOL. 15, 8, p. 897-907 11 p.

Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

View all (14)